These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35886450)

  • 1. Occupational Exposure Assessment to Antineoplastic Drugs in Nine Italian Hospital Centers over a 5-Year Survey Program.
    Sottani C; Grignani E; Cornacchia M; Negri S; Cuna FSRD; Cottica D; Bruzzese D; Severi P; Strocchi D; Verna G; Leso V; Iavicoli I
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring Surface Contamination by Antineoplastic Drugs in Italian Hospitals: Performance-Based Hygienic Guidance Values (HGVs) Project.
    Sottani C; Grignani E; Oddone E; Dezza B; Negri S; Villani S; Cottica D
    Ann Work Expo Health; 2017 Oct; 61(8):994-1002. PubMed ID: 29028251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels and risks of surface contamination by thirteen antineoplastic drugs in the Czech and Slovak hospitals and pharmacies.
    Doležalová L; Bláhová L; Kuta J; Hojdarová T; Kozáková Š; Bláha L
    Environ Sci Pollut Res Int; 2022 Apr; 29(18):26810-26819. PubMed ID: 34855176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial and Temporal Variability in Antineoplastic Drug Surface Contamination in Cancer Care Centers in Alberta and Minnesota.
    Jeronimo M; Arnold S; Astrakianakis G; Lyden G; Stewart Q; Petersen A; Chambers C; Malard Johnson D; Zimdars E; Kaup H; Davies HW
    Ann Work Expo Health; 2021 Aug; 65(7):760-774. PubMed ID: 33889938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study: External surface contamination of gemcitabine and 5-fluorouracil on drug packaging.
    Kåredal M; Özdemir J; Tinnert A; Wetterling M; Hedmer M
    J Oncol Pharm Pract; 2024 Jan; 30(1):9-14. PubMed ID: 36916178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of long-term data on surface contamination by antineoplastic drugs in pharmacies.
    Quartucci C; Rooney JPK; Nowak D; Rakete S
    Int Arch Occup Environ Health; 2023 Jul; 96(5):675-683. PubMed ID: 36877242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 124 centers.
    Pinet E; Cirtiu CM; Caron N; Bussières JF; Tanguay C
    J Oncol Pharm Pract; 2024 Jan; 30(1):19-29. PubMed ID: 37021440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 122 centers.
    Delafoy C; Roussy C; Hudon AF; Cirtiu CM; Caron N; Bussières JF; Tanguay C
    J Oncol Pharm Pract; 2023 Mar; 29(2):338-347. PubMed ID: 35018847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidance values for surface monitoring of antineoplastic drugs in German pharmacies.
    Schierl R; Böhlandt A; Nowak D
    Ann Occup Hyg; 2009 Oct; 53(7):703-11. PubMed ID: 19620232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposals of guidance values for surface contamination by antineoplastic drugs based on long term monitoring in Czech and Slovak hospitals and pharmacies.
    Bláhová L; Bláha L; Doležalová L; Kuta J; Hojdarová T
    Front Public Health; 2023; 11():1235496. PubMed ID: 37780438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals.
    Hedmer M; Wohlfart G
    J Environ Monit; 2012 Jul; 14(7):1968-75. PubMed ID: 22692549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of novel field measurement and field evaluation protocols for assessing health care workers' exposure risk to antineoplastic drugs.
    Astrakianakis G; Jeronimo M; Griffiths A; Colombo M; Kramer D; Demers PA; Hon CY
    J Occup Environ Hyg; 2020 Sep; 17(9):373-382. PubMed ID: 32615872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational exposure to antineoplastic drugs in four Italian health care settings.
    Sottani C; Porro B; Imbriani M; Minoia C
    Toxicol Lett; 2012 Aug; 213(1):107-15. PubMed ID: 21477641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to antineoplastic drugs in two UK hospital pharmacy units.
    Mason HJ; Blair S; Sams C; Jones K; Garfitt SJ; Cuschieri MJ; Baxter PJ
    Ann Occup Hyg; 2005 Oct; 49(7):603-10. PubMed ID: 15964878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface contamination with ten antineoplastic drugs in 83 Canadian centers.
    Chauchat L; Tanguay C; Caron NJ; Gagné S; Labrèche F; Bussières JF
    J Oncol Pharm Pract; 2019 Jul; 25(5):1089-1098. PubMed ID: 29726786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter study of environmental contamination with antineoplastic drugs in 33 Canadian hospitals.
    Merger D; Tanguay C; Langlois E; Lefebvre M; Bussières JF
    Int Arch Occup Environ Health; 2014 Apr; 87(3):307-13. PubMed ID: 23471647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between occupational exposure and control measures for antineoplastic drugs in a pharmacy of a hospital.
    Yoshida J; Koda S; Nishida S; Nakano H; Tei G; Kumagai S
    Ann Occup Hyg; 2013 Mar; 57(2):251-60. PubMed ID: 23002276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach to assessing occupational exposure to antineoplastic drugs in hospital environments.
    Dugheri S; Bonari A; Pompilio I; Boccalon P; Mucci N; Arcangeli G
    Arh Hig Rada Toksikol; 2018 Sep; 69(3):226-237. PubMed ID: 30285941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies - the MEWIP project.
    Kiffmeyer TK; Tuerk J; Hahn M; Stuetzer H; Hadtstein C; Heinemann A; Eickmann U
    Ann Occup Hyg; 2013 May; 57(4):444-55. PubMed ID: 23125441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational exposure to antineoplastic drugs in hospital environments: potential risk associated with contact with cyclophosphamide- and ifosfamide-contaminated surfaces.
    Mucci N; Dugheri S; Farioli A; Garzaro G; Rapisarda V; Campagna M; Bonari A; Arcangeli G
    Med Pr; 2020 Sep; 71(5):519-529. PubMed ID: 32667290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.